Work

A Novel Anti-CD22 Immunotoxin, Moxetumomab Pasudotox: Phase I Study in Pediatric Acute Lymphoblastic Leukemia (ALL)

Year: 2011

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v118.21.248.248

Authors: Alan S Wayne, Deepa Bhojwani, Lewis B. Silverman, Kelly Richards, Maryalice Stetler-Stevenson, Nirali N Shah, Sima Jeha, Ching-Hon Pui, Manuela Buzoianu, David J. FitzGerald, Robert J. Kreitman, Ramy Ibrahim, Ira Pastan

Institutions: National Institutes of Health, National Cancer Institute, Center for Cancer Research, St. Jude Children's Research Hospital, Boston Children's Hospital, Dana-Farber Cancer Institute, Dana-Farber/Boston Children's Cancer and Blood Disorders Center

Language: English

Topic: Toxin Mechanisms and Immunotoxins

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2592851172

FWCI: 4.435

Cites:

Cited by: 57

Related to: 10